Abstract
A nationwide cohort study has found an increased risk of cardiac malformations in infants exposed to methylphenidate during the first trimester of pregnancy, but no increased risk of overall congenital malformations from exposure to either methylphenidate or amphetamine. The study represented the first use of a research collaboration under which findings from the U.S. study were replicated using pregnancy registry data from five countries in the Nordic region.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
